Business Context and Reporting Period
This Form 8-K is a current report filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on March 1, 2013. The filing reports material corporate governance changes, specifically the departure of a director and the appointment of a new director, effective March 1, 2013.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
- Departure of Director: Gregg Alton resigned as a member of the Board of Directors, Chairman of the Nominating and Corporate Governance Committee, and member of the Audit Committee for personal reasons.
- Appointment of New Director: Jerry McLaughlin was appointed as a director, a non-chairperson member of the Audit Committee, and Chair of the Nominating and Corporate Governance Committee.
- Compensation Arrangements: Mr. McLaughlin will receive an annual retainer of $25,000, plus $5,000 for Audit Committee service and $5,000 for Nominating Committee chairmanship. He may elect stock options in lieu of cash.
- Equity Grant: Mr. McLaughlin was granted an option to purchase 50,000 shares, vesting over three years (one-third on the first anniversary, remainder monthly).
- Indemnification: An indemnification agreement was entered into with Mr. McLaughlin effective March 1, 2013.
Outlook, Risks, and Contingencies
The filing contains forward-looking statements regarding the company's future activities and a planned spin-off of a separate public company. Management notes that actual outcomes may differ due to risks including:
- Uncertainties associated with effecting the spin-off.
- The discretion of the Board of Directors to delay or cancel the spin-off prior to execution.
Key Facts for Investor Verification
- Verify the current status of the planned spin-off mentioned in the forward-looking statements.
- Confirm the vesting schedule and exercise terms of the 50,000 share option granted to Jerry McLaughlin.
- Review the company's most recent Form 10-K for detailed financial data, as this 8-K contains no financial metrics.
- Check for any subsequent filings regarding the composition of the Board of Directors following Mr. Alton's resignation.